Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Jessner's vs Glycolic Acid with TCA for Melasma
NCT03153852Phase 4Unknown
- Sponsor
- Assiut University
- Start
- Mar 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
01
Overview
Phase 4, open-label trial of modified jessner's solution and Glycolic acid in melasma (2 arms), sponsored by Assiut University. Primary endpoint: Melasma Area and Severity Index at 12 weeks. Status: unknown.
02
Drugs
modified jessner's solutionGlycolic acid
03
Conditions
melasma
Beyond the preview
Go deeper on NCT03153852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03153852.